笃志创新 躬行致远:世界卫生组织《2023年全球结核病报告》结核病科学研究章节解读

Dedicating to innovation,practicing to achieve targets:interpretation of research&innovation part of the WHO Global Tuberculosis Report 2023

结核病领域创新性的研究与发展是终止结核病策略三大支柱之一,新技术和新策略是加速消除结核病进程的重要工具。2023年11月7日,世界卫生组织发布了《2023年全球结核病报告》,对全球结核病的流行情况,以及全球、区域和国家各级在预防、诊断和治疗结核病方面取得的进展进行更新。笔者就报告中结核病研究领域新诊断技术、新药与新方案及新疫苗等的研究及创新要点进行综述,并结合我国相关领域的研究进展进行分析,以期为我国结核病防治领域同行掌握结核病研究动态,进一步开展原创性研究和技术提供参考。

“Intensified research and innovation”is the third pillar of the End TB Strategy,new research and technology are important tools to accelerate the process of eliminating tuberculosis(TB).On November 7,2023,World Health Organization released the Global Tuberculosis Report 2023,updating the global prevalence of TB and the progress in the prevention,diagnosis and treatment.This paper reviews the key achievements in the areas of TB research and innovation for new diagnostics,drugs and regimens as well as vaccines introduced in the report,and discusses some of China’s indigenous progresses in related areas.This paper aims to make China’s TB professionals better informed about the latest research development in TB prevention and control around the globe,fostering indigenous TB innovation efforts with greater originality.